Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.
Lantz A, Bock D, Akre O, Angenete E, Bjartell A, Carlsson S, Modig KK, Nyberg M, Kollberg KS, Steineck G, et al. Functional and oncological outcomes after open versus robot-assisted laparoscopic radical prostatectomy for localised prostate cancer: 8 year follow-up. Eur Urol. 2021;80:650–60.
Article CAS PubMed Google Scholar
Yossepowitch O, Briganti A, Eastham JA, Epstein J, Graefen M, Montironi R, Touijer K. Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. Eur Urol. 2014;65:303–13.
Wright JL, Dalkin BL, True LD, Ellis WJ, Stanford JL, Lange PH, Lin DW. Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality. J Urol. 2010;183:2213–8.
Article PubMed PubMed Central Google Scholar
Zaorsky NG, Calais J, Fanti S, Tilki D, Dorff T, Spratt DE, Kishan AU. Salvage therapy for prostate cancer after radical prostatectomy. Nat Rev Urol. 2021;18:643–68.
Cheng Q, Butler W, Zhou Y, Zhang H, Tang L, Perkinson K, Chen X, Jiang XS, McCall SJ, Inman BA, Huang J. Pre-existing castration-resistant prostate cancer-like cells in primary prostate cancer promote resistance to hormonal therapy. Eur Urol. 2022;81:446–55.
Article CAS PubMed PubMed Central Google Scholar
Perera M, Krishnananthan N, Lindner U, Lawrentschuk N. An update on focal therapy for prostate cancer. Nat Rev Urol. 2016;13:641–53.
Article CAS PubMed Google Scholar
Reddy D, Peters M, Shah TT, van Son M, Tanaka MB, Huber PM, Lomas D, Rakauskas A, Miah S, Eldred-Evans D, et al. Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: a multi-institute 15 year experience. Eur Urol. 2022;81:407–13.
Bakavicius A, Marra G, Macek P, Robertson C, Abreu AL, George AK, Malavaud B, Coloby P, Rischmann P, Moschini M, et al. Available evidence on hifu for focal treatment of prostate cancer: a systematic review. Int Braz J Urol. 2022;48:263–74.
Shoji S, Kuroda S, Uemura K, Oda K, Kano T, Ogawa T, Umemoto T, Nakano M, Kawakami M, Nitta M, et al. Risk factors for severe erectile dysfunction after focal therapy with high-intensity focused ultrasound for prostate cancer. Biomedicines. 2022;10:2876.
Article PubMed PubMed Central Google Scholar
Borges RC, Tourinho-Barbosa RR, Glina S, Macek P, Mombet A, Sanchez-Salas R, Cathelineau X. Impact of focal versus whole gland ablation for prostate cancer on sexual function and urinary continence. J Urol. 2021;205:129–36.
Li B, Zhao M, Lin J, Huang P, Chen X. Management of fluorescent organic/inorganic nanohybrids for biomedical applications in the NIR-II region. Chem Soc Rev. 2022;51:7692–714.
Article CAS PubMed Google Scholar
Kenry, Duan Y, Liu B. Recent advances of optical imaging in the second near-infrared window. Adv Mater. 2018;30:e1802394.
Article CAS PubMed Google Scholar
Afshari MJ, Li C, Zeng J, Cui J, Wu S, Gao M. Self-illuminating NIR-II bioluminescence imaging probe based on silver sulfide quantum dots. ACS Nano. 2022;16:16824–32.
Article CAS PubMed Google Scholar
Li D, Liu Q, Qi Q, Shi H, Hsu EC, Chen W, Yuan W, Wu Y, Lin S, Zeng Y, et al. Gold nanoclusters for NIR-II fluorescence imaging of bones. Small. 2020;16: e2003851.
Zhang Y, Shen Q, Li Q, He P, Li J, Huang F, Wang J, Duan Y, Shen C, Saleem F, et al. Ultrathin two-dimensional plasmonic ptag nanosheets for broadband phototheranostics in both NIR-I and NIR-II biowindows. Adv Sci. 2021;8: e2100386.
Zhu S, Tian R, Antaris AL, Chen X, Dai H. Near-infrared-II molecular dyes for cancer imaging and surgery. Adv Mater. 2019;31: e1900321.
Article PubMed PubMed Central Google Scholar
Hu Z, Fang C, Li B, Zhang Z, Cao C, Cai M, Su S, Sun X, Shi X, Li C, et al. First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows. Nat Biomed Eng. 2020;4:259–71.
Chen QY, Xie JW, Zhong Q, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, et al. Safety and efficacy of indocyanine green tracer-guided lymph node dissection during laparoscopic radical gastrectomy in patients with gastric cancer: a randomized clinical trial. JAMA Surg. 2020;155:300–11.
Yang X, Shi C, Tong R, Qian W, Zhau HE, Wang R, Zhu G, Cheng J, Yang VW, Cheng T, et al. Near IR heptamethine cyanine dye-mediated cancer imaging. Clin Cancer Res. 2010;16:2833–44.
Article CAS PubMed PubMed Central Google Scholar
Li Y, Zhang J, Zhu L, Jiang M, Ke C, Long H, Lin R, Ye C, Zhou X, Jiang ZX, Chen S. All-in-one heptamethine cyanine amphiphiles for dual imaging-guided chemo-photodynamic-photothermal therapy of breast cancer. Adv Healthc Mater. 2023;12: e2300941.
Li DH, Schreiber CL, Smith BD. Sterically shielded heptamethine cyanine dyes for bioconjugation and high performance near-infrared fluorescence imaging. Angew Chem Int Ed Engl. 2020;59:12154–61.
Article CAS PubMed PubMed Central Google Scholar
Liu T, Chen Y, Wang H, Cui M, Zhang J, Zhang W, Wang P. Phototheranostic agents based on nonionic heptamethine cyanine for realizing synergistic cancer phototherapy. Adv Healthc Mater. 2023;12: e2202817.
Li Q, Chen K, Huang W, Ma H, Zhao X, Zhang J, Zhang Y, Fang C, Nie L. Minimally invasive photothermal ablation assisted by laparoscopy as an effective preoperative neoadjuvant treatment for orthotopic hepatocellular carcinoma. Cancer Lett. 2021;496:169–78.
Article CAS PubMed Google Scholar
Yang X, Gao L, Wei Y, Tan B, Wu Y, Yi C, Liao J. Photothermal hydrogel platform for prevention of post-surgical tumor recurrence and improving breast reconstruction. J Nanobiotechnol. 2021;19:307.
Luo S, Tan X, Qi Q, Guo Q, Ran X, Zhang L, Zhang E, Liang Y, Weng L, Zheng H, et al. A multifunctional heptamethine near-infrared dye for cancer theranosis. Biomaterials. 2013;34:2244–51.
Article CAS PubMed Google Scholar
Shi C, Zhang C, Su Y, Cheng T. Cyanine dyes in optical imaging of tumours. Lancet Oncol. 2010;11:815–6.
Wang S, Zhou L, Tian H, Li B, Su M, Li Q, Nice EC, Huang C, Shao J, He T. Site-specific nanomodulator capable of modulation apoptosis for enhanced colorectal cancer chemo-photothermal therapy. J Nanobiotechnol. 2023;21:24.
Lv Q, Yang X, Wang M, Yang J, Qin Z, Kan Q, Zhang H, Wang Y, Wang D, He Z. Mitochondria-targeted prostate cancer therapy using a near-infrared fluorescence dye–monoamine oxidase a inhibitor conjugate. J Control Releas. 2018;279:234–42.
Liu L, Yang S, Zheng Z, Li Q, Liu C, Hu D, Liu Z, Zhang X, Zhang R, Gao D. Biomimetic theranostic agents with superior NIR-II photoacoustic and magnetic resonance imaging performance for targeted photothermal therapy of prostate cancer. Pharmaceutics. 2023;15:1617.
Article PubMed PubMed Central Google Scholar
Wang Q, Xu J, Geng R, Cai J, Li J, Xie C, Tang W, Shen Q, Huang W, Fan Q. High performance one-for-all phototheranostics: NIR-II fluorescence imaging guided mitochondria-targeting phototherapy with a single-dose injection and 808 nm laser irradiation. Biomaterials. 2020;231: 119671.
Article CAS PubMed Google Scholar
Li X, Yong T, Wei Z, Bie N, Zhang X, Zhan G, Li J, Qin J, Yu J, Zhang B, et al. Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts. Nat Commun. 2022;13:2794.
Article CAS PubMed PubMed Central Google Scholar
Jiang R, Dai J, Dong X, Wang Q, Meng Z, Guo J, Yu Y, Wang S, Xia F, Zhao Z, et al. Improving image-guided surgical and immunological tumor treatment efficacy by photothermal and photodynamic therapies based on a multifunctional NIR AIEgen. Adv Mater. 2021;33: e2101158.
Qu Q, Zhang Z, Guo X, Yang J, Cao C, Li C, Zhang H, Xu P, Hu Z, Tian J. Novel multifunctional NIR-II aggregation-induced emission nanoparticles-assisted intraoperative identification and elimination of residual tumor. J Nanobiotechnol. 2022;20:143.
Wei Q, Arami H, Santos HA, Zhang H, Li Y, He J, Zhong D, Ling D, Zhou M. Intraoperative assessment and photothermal ablation of the tumor margins using gold nanoparticles. Adv Sci. 2021;8:2002788.
Wen Y, Truong VX, Li M. Real-time intraoperative surface-enhanced raman spectroscopy-guided thermosurgical eradication of residual microtumors in orthotopic breast cancer. Nano Lett. 2021;21:3066–74.
留言 (0)